A couple of questions from my side. Sir, first for the quarterly perspective, our subsidiary revenue stands at roughly almost around INR92 crores. Can you please give the broad-based bifurcation of what kind of revenues will be from the PendraCare for the quarter? And what kind of revenues from the Citieffe? And what will be the Y-o-Y percentage growth rate of these 2? That's my first question.
Okay. And sir, if I see from the stand-alone level, right, since you mentioned that INR30 crores only increase in inventory just because if you see the FY '26, our growth rate is around 4-5%. That's why probably it doesn't look so. But if we see from the perspective of the days, inventory days has increased from 50 to 58 days. How we are planning to reduce that? And apart from inventory days, if you see the receivables, which has increased drastically from, let's say, INR340 crores to INR440 crores. Like in the terms of days, it's 68 days to 86 days. So can you just help me -- can you throw some light on that? How do we see that?